XML 20 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities        
Net loss $ (163,960) $ (262,570) $ (252,911) $ (402,157)
Adjustments to reconcile net loss to net cash provided by operating activities:        
Depreciation and amortization 46,945 40,023 91,641 77,738
Stock-based compensation 263,189 251,886 513,229 499,224
Amortization of debt issuance costs and debt discount (premium) (967) (550) (1,898) 7,092
Losses (gains) on debt and equity securities, net (129) (1,208) 716 14,592
Gain on extinguishment of debt 0 0 0 (66,939)
Other 10,909 12,362 16,035 11,557
Change in operating assets and liabilities, net of effect of acquisitions:        
Accounts receivable, net of allowance (67,614) (3,088) 107,021 191,128
Prepaid expenses and other current assets (14,460) (7,058) (30,730) (29,886)
Operating lease right-of-use assets 15,734 13,797 30,848 27,920
Other assets 159 (2,117) (81) 6,893
Accounts payable (59,745) (94,203) (37,701) (59,943)
Accrued expenses and other current liabilities 155,599 147,695 87,950 (14,873)
Operating lease liabilities (9,011) (8,492) (21,466) (25,485)
Other liabilities (435) 2,017 340 3,243
Net cash provided by operating activities 176,214 88,494 502,993 240,104
Cash flows from investing activities        
Purchases of property and equipment (55,676) (64,701) (96,448) (101,915)
Purchases of strategic investments 0 (20,000) (5,934) (20,000)
Cash paid for acquisitions, net of cash acquired (25,678) (35,499) (65,048) (35,499)
Purchases of marketable securities (213,798) (390,866) (516,158) (626,665)
Sales of marketable securities 55,359 425,157 287,457 437,158
Maturities of marketable securities 216,138 301,348 429,738 565,114
Other (500) 0 (500) 0
Net cash provided by (used in) investing activities (24,155) 215,439 33,107 218,193
Cash flows from financing activities        
Proceeds from issuance of notes, net of issuance costs 0 0 0 1,473,083
Repurchases of Class A non-voting common stock (250,465) (243,473) (600,964) (500,573)
Deferred payments for acquisitions (2,642) (9,562) (2,642) (67,539)
Repurchases of convertible notes 0 0 0 (1,444,626)
Repayment of convertible notes 0 (36,240) 0 (36,240)
Other (1,799) (1,800) (3,400) (3,699)
Net cash used in financing activities (254,906) (291,075) (607,006) (579,594)
Change in cash, cash equivalents, and restricted cash (102,847) 12,858 (70,906) (121,297)
Cash, cash equivalents, and restricted cash, beginning of period 1,063,338 916,079 1,031,397 1,050,234
Cash, cash equivalents, and restricted cash, end of period $ 960,491 $ 928,937 $ 960,491 $ 928,937